Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$200.6M
+307.2% from 2023
Prescriptions
9,927
$20,203.69 per claim
Patients
1,795
1,550 prescribers
Total spending, 2024
$200.6M
$111,733.72 per patient
Medicare prescription drug plans paid $200.6M for Jaypirca in 2024, for 9,927 prescriptions and refills to 1,795 patients (up 307.2% from 2023). The average cost per claim was $20,203.69.
New York had the highest Medicare cost for Jaypirca in 2024: $22.6M for 1,084 claims, followed by California ($21.3M).
Leslie A Rudolph, physician assistant in New York, NY, had the highest Medicare cost for Jaypirca in 2024: 127 claims costing $2.7M.
Jaypirca is made by Eli Lilly and Company (LLY), listed in the Medicare spending data as Eli Lilly & Co..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Leslie A Rudolph New York, NY | Physician Assistant | 127 | 25 | $2.7M |
| Richard R Furman New York, NY | Medical Oncology | 83 | 21 | $1.7M |
| Kasey L Weisbrod |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2023 | 588 | 2,298 | 647 | $49.3M |
| 2024 | 1,550 | 9,927 | 1,795 | $200.6M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims |
|---|
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Nurse Practitioner |
| 76 |
| Under 11 |
| $1.5M |
| Brian T Hill Cleveland, OH | Hematology-Oncology | 71 | 11 | $1.4M |
| Thomas J Kipps La Jolla, CA | Hematology-Oncology | 52 | Under 11 | $1.1M |
| Jennifer A Woyach Columbus, OH | Hematology | 49 | Under 11 | $1.0M |
| Nancy L Bartlett Saint Louis, MO | Medical Oncology | 46 | Under 11 | $1.0M |
| Marc S Hoffmann Overland Park, KS | Hematology-Oncology | 48 | 12 | $959K |
| Danielle T Land Philadelphia, PA | Nurse Practitioner | 50 | Under 11 | $915K |
| Kerry A Rogers Columbus, OH | Hematology | 43 | Under 11 | $862K |
| Kelly G Davey Irvine, CA | Nurse Practitioner | 41 | Under 11 | $823K |
| Richard C Frank Norwalk, CT | Medical Oncology | 36 | Under 11 | $801K |
| Tanya Siddiqi Duarte, CA | Hematology | 34 | Under 11 | $753K |
| Alice Lynn Houston, TX | Nurse Practitioner | 34 | Under 11 | $736K |
| Stefano Tarantolo Omaha, NE | Medical Oncology | 33 | Under 11 | $733K |
| John C Hughes Saginaw, MI | Hematology-Oncology | 34 | Under 11 | $700K |
| Jose F Leis Scottsdale, AZ | Hematopoietic Cell Transplantation and Cellular Therapy | 29 | Under 11 | $660K |
| Bradley W Lash Allentown, PA | Hematology-Oncology | 32 | Under 11 | $656K |
| Stephen E Spurgeon Portland, OR | Hematology-Oncology | 29 | Under 11 | $647K |
| Ian W Flinn Nashville, TN | Hematology-Oncology | 29 | Under 11 | $606K |
| Jefferson M Prichard Charlottesville, VA | Hematology-Oncology | 27 | Under 11 | $602K |
| Paul M Barr Rochester, NY | Hematopoietic Cell Transplantation and Cellular Therapy | 27 | Under 11 | $587K |
| Christina M Patterson York, PA | Physician Assistant | 27 | Under 11 | $585K |
| Nina D Wagner-Johnston Baltimore, MD | Medical Oncology | 27 | Under 11 | $582K |
| Christina Baldwin New York, NY | Nurse Practitioner | 31 | Under 11 | $567K |
| Spending |
|---|
| Eli Lilly & Co. LLY | 9,927 | $200.6M |